A Study to Test BI 655130 in Patients With a Flare-up of a Skin Disease Called Generalized Pustular Psoriasis
Status:
Completed
Trial end date:
2021-01-05
Target enrollment:
Participant gender:
Summary
To evaluate efficacy, safety, and tolerability of BI 655130 compared to placebo in patients
with Generalized Pustular Psoriasis (GPP) presenting with an acute flare of moderate to
severe intensity.